HUTCHMED (China) Limited (AIM:HCM)
160.00
0.00 (0.00%)
Jun 29, 2026, 4:35 PM GMT
HUTCHMED (China) Employees
HUTCHMED (China) had 1,796 employees as of December 31, 2025. The number of employees decreased by 15 or -0.83% compared to the previous year.
Employees
1,796
Change (1Y)
-15
Growth (1Y)
-0.83%
Revenue / Employee
226.92K GBP
Profits / Employee
189.02K GBP
Market Cap
1.38B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Hikma Pharmaceuticals | 9,400 |
| Allergy Therapeutics | 584 |
| Venture Life Group | 43 |
| Haleon | 24,535 |
| ECO Animal Health Group | 200 |
| Provexis | 2 |
| Chill Brands Group | 11 |
HUTCHMED (China) News
- 4 days ago - HUTCHMED Registrational Phase 2 Trial Meets Primary Endpoint For Fanregratinib In Bile Duct Cancer - Nasdaq
- 6 days ago - Syndio Acquires Embrace.ai - Business Wire
- 12 days ago - HUTCHMED (China) Ltd (HCM) Shares Fall 3.5% -- What GF Score of 81 Tells Investors - GuruFocus
- 13 days ago - Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM) - PRNewsWire
- 13 days ago - isolved Honors Top-Performing Partners at Annual Connect for Partners Event - GlobeNewsWire
- 14 days ago - isolved Introduces New Strategic Marketplace Partners at Connect 2026, Extending People Cloud™ Capabilities for Employers and Employees - GlobeNewsWire
- 14 days ago - Paychex Recognized as a Top WorkTech Company by TIME - GlobeNewsWire
- 17 days ago - HUTCHMED's Sovleplenib Meets Phase III Goal In WAIHA, Showing 66% Durable Response Rate; Stock Up - Nasdaq